Clinical Trial: To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514780) titled 'To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers' on Feb. 23.

Brief Summary: This clinical study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation clinical trial to evaluate the safety, pharmacokinetic and pharmacodynamics of JW0061 following topical application in Korean and Caucasians healthy adults.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: JW0061 SAD

Single ascending doses

DRUG: JW0061 MAD

Multiple ascending doses

DRUG: Placebo

Matching placebo for JW0061

Recruitment Status: NOT_YET_RECRUITING

Spo...